Shizhan Ma

867 total citations
28 papers, 528 citations indexed

About

Shizhan Ma is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shizhan Ma has authored 28 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Epidemiology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shizhan Ma's work include Liver Disease Diagnosis and Treatment (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Thyroid Disorders and Treatments (4 papers). Shizhan Ma is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Thyroid Disorders and Treatments (4 papers). Shizhan Ma collaborates with scholars based in China and Romania. Shizhan Ma's co-authors include Ling Gao, Jiajun Zhao, Xinhuan Su, Yang Li, Zhe Wang, Ying Zhao, Shudong Liu, Chao Xu, Chunxiao Yu and Fei Jing and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecular and Cellular Endocrinology.

In The Last Decade

Shizhan Ma

25 papers receiving 523 citations

Peers

Shizhan Ma

EDM

PHYSI

EPIDE

Daisuke Mikami Japan

Francesca Pacifici Italy

Heng Miao China

Ilhame Diboun Qatar

Kévin Garbin France

Traci E. LaMoia United States

Nuria Beneit Spain

Mohammad A. Uddin United States

Hengjiang Guo China

Daisuke Mikami Japan

Shizhan Ma

334 ×1.4

94 ×0.6

EDM

153 ×1.2

PHYSI

63 ×0.8

EPIDE

47 ×0.6

Citations per year, relative to Shizhan Ma Shizhan Ma (= 1×) peers Daisuke Mikami

Countries citing papers authored by Shizhan Ma

Since Specialization

Citations

This map shows the geographic impact of Shizhan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shizhan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shizhan Ma more than expected).

Fields of papers citing papers by Shizhan Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shizhan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shizhan Ma. The network helps show where Shizhan Ma may publish in the future.

Co-authorship network of co-authors of Shizhan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Shizhan Ma. A scholar is included among the top collaborators of Shizhan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shizhan Ma. Shizhan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Shizhan, et al.. (2025). Artificial intelligence and medical-engineering integration in diabetes management: Advances, opportunities, and challenges. 1(1). 100006–100006. 1 indexed citations

Jiang, Bei, Tao Sun, Rui‐Hua Xu, et al.. (2025). Metabolomic profiling reveals interindividual metabolic variability and its association with cardiovascular-kidney-metabolic syndrome risk. Cardiovascular Diabetology. 24(1). 315–315. 1 indexed citations

Zhang, Haiqing, Xiaowei Chen, Hou-Yu Zhao, et al.. (2025). Effect of levothyroxine on major adverse cardiovascular events in patients with hypothyroidism and cardiovascular disease. Frontiers in Endocrinology. 16. 1640086–1640086.

Shao, Shanshan, et al.. (2024). Exploring the link between obesity and hypothyroidism in autoimmune thyroid diseases: a metabolic perspective. Frontiers in Molecular Biosciences. 11. 1379124–1379124. 3 indexed citations

Du, Jing, Shizhan Ma, Fang Li, et al.. (2023). Association between Regional Body Muscle Mass and Non-Alcoholic Fatty Liver Disease: An Observational Study Using Data from the REACTION Study. Journal of Personalized Medicine. 13(2). 209–209. 3 indexed citations

Wang, Yanyan, et al.. (2023). Association of Obesity based on Different Metabolic Status with Risk of Gout Occurrence in Patients: A National Study. Endocrine Metabolic & Immune Disorders - Drug Targets. 24(8). 973–980. 4 indexed citations

Liu, Shudong, Fengxia Zhang, Xinhuan Su, et al.. (2023). The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP/PS1 mice. Journal of Translational Medicine. 21(1). 657–657. 7 indexed citations

Wu, Dongming, et al.. (2023). The effect of G0S2 on insulin sensitivity: A proteomic analysis in a G0S2-overexpressed high-fat diet mouse model. Frontiers in Endocrinology. 14. 1130350–1130350. 2 indexed citations

Ma, Shizhan, Wenkai Bi, Xueying Liu, et al.. (2022). Single-Cell Sequencing Analysis of the db/db Mouse Hippocampus Reveals Cell-Type-Specific Insights Into the Pathobiology of Diabetes-Associated Cognitive Dysfunction. Frontiers in Endocrinology. 13. 891039–891039. 31 indexed citations

10.

Wang, Yupeng, Qihang Li, Zhongshang Yuan, et al.. (2021). Statin Use and Benefits of Thyroid Function: A Retrospective Cohort Study. Frontiers in Endocrinology. 12. 578909–578909. 12 indexed citations

11.

Yin, Qingqing, Jian Chen, Shizhan Ma, et al.. (2020). <p>Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro</p>. Journal of Inflammation Research. Volume 13. 533–542. 36 indexed citations

12.

Shao, Shanshan, Zhiwei Li, Zhenhua Dong, et al.. (2020). FSHR ablation induces depression-like behaviors. Acta Pharmacologica Sinica. 41(8). 1033–1040. 14 indexed citations

13.

Ma, Shizhan, et al.. (2019). <p>Therapeutic targets of hypercholesterolemia: HMGCR and LDLR</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 1543–1553. 44 indexed citations

14.

Jia, Ning, Xiaoyan Lin, Shizhan Ma, et al.. (2018). Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice. Nutrition & Metabolism. 15(1). 86–86. 33 indexed citations

15.

Zhang, Fengxia, Jianbo Chen, Ping Yang, et al.. (2018). SREBP-2, a new target of metformin?. Drug Design Development and Therapy. Volume 12. 4163–4170. 19 indexed citations

16.

Yao, Zhenyu, Wenbin Chen, Shanshan Shao, et al.. (2018). Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders. Journal of Zhejiang University SCIENCE B. 19(3). 183–198. 42 indexed citations

17.

Li, Yujie, Laicheng Wang, Lingyan Zhou, et al.. (2017). Thyroid stimulating hormone increases hepatic gluconeogenesis via CRTC2. Molecular and Cellular Endocrinology. 446. 70–80. 45 indexed citations

18.

Ma, Shizhan, Fei Jing, Chao Xu, et al.. (2015). Thyroid-Stimulating Hormone Inhibits Adipose Triglyceride Lipase in 3T3-L1 Adipocytes through the PKA Pathway. PLoS ONE. 10(1). e0116439–e0116439. 25 indexed citations

19.

Ma, Shizhan, Fei Jing, Chao Xu, et al.. (2015). Thyrotropin and Obesity: Increased Adipose Triglyceride Content Through Glycerol-3-Phosphate Acyltransferase 3. Scientific Reports. 5(1). 7633–7633. 55 indexed citations

20.

Ma, Shizhan, et al.. (2010). Various Novel Erythromycin Derivatives Obtained by Different Modifications: Recent Advance in Macrolide Antibiotics. Mini-Reviews in Medicinal Chemistry. 10(4). 272–286. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact